254 related articles for article (PubMed ID: 17965520)
1. Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex.
Ishii Y; Iwanaga M; Nishimura Y; Takeda S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Pharmacokinet; 2007 Oct; 22(5):367-76. PubMed ID: 17965520
[TBL] [Abstract][Full Text] [Related]
2. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
Kobayashi K; Urashima K; Shimada N; Chiba K
Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase in the regenerating rat liver.
Pellizzer AM; Smid SA; Strasser SI; Lee CS; Mashford ML; Desmond PV
J Gastroenterol Hepatol; 1996 Dec; 11(12):1130-6. PubMed ID: 9034932
[TBL] [Abstract][Full Text] [Related]
6. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1.
Ozawa S; Ohta K; Miyajima A; Kurebayashi H; Sunouchi M; Shimizu M; Murayama N; Matsumoto Y; Fukuoka M; Ohno Y
Xenobiotica; 2000 Oct; 30(10):1005-17. PubMed ID: 11315102
[TBL] [Abstract][Full Text] [Related]
8. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes.
Serron SC; Dwivedi N; Backes WL
Toxicol Appl Pharmacol; 2000 May; 164(3):305-11. PubMed ID: 10799341
[TBL] [Abstract][Full Text] [Related]
9. Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4.
Fremont JJ; Wang RW; King CD
Mol Pharmacol; 2005 Jan; 67(1):260-2. PubMed ID: 15486048
[TBL] [Abstract][Full Text] [Related]
10. Effect of 4-tert-octylphenol on cytochrome P450 enzymes in rat liver.
Hanioka N; Jinno H; Chung YS; Nishimura T; Tanaka-Kagawa T; Ando M
Arch Toxicol; 2000 Feb; 73(12):625-31. PubMed ID: 10741473
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats.
Yun KU; Oh SJ; Oh JM; Kang KW; Myung CS; Song GY; Kim BH; Kim SK
Arch Toxicol; 2010 Dec; 84(12):939-46. PubMed ID: 20130842
[TBL] [Abstract][Full Text] [Related]
12. Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver.
Fabrizi L; Gemma S; Testai E; Vittozzi L
J Biochem Mol Toxicol; 1999; 13(1):53-61. PubMed ID: 9890448
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
14. Nutritional status modulates rat liver cytochrome P450 arachidonic acid metabolism.
Qu W; Rippe RA; Ma J; Scarborough P; Biagini C; Fiedorek FT; Travlos GS; Parker C; Zeldin DC
Mol Pharmacol; 1998 Sep; 54(3):504-13. PubMed ID: 9730909
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of Efavirenz and Proteomic Analysis of Cytochrome P450s and UDP-Glucuronosyltransferases in Mouse, Macaque, and Human Brain-Derived In Vitro Systems.
Wheeler AM; Orsburn BC; Bumpus NN
Drug Metab Dispos; 2023 Apr; 51(4):521-531. PubMed ID: 36623884
[TBL] [Abstract][Full Text] [Related]
16. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation.
Imaoka S; Osada M; Minamiyama Y; Yukimura T; Toyokuni S; Takemura S; Hiroi T; Funae Y
Cancer Lett; 2004 Jan; 203(2):117-25. PubMed ID: 14732219
[TBL] [Abstract][Full Text] [Related]
17. Effects of the bacterial status of rats on the changes in some liver cytochrome P450 (EC 1.14.14.1) apoproteins consequent to a glucosinolate-rich diet.
Nugon-Baudon L; Rabot S; Flinois JP; Lory S; Beaune P
Br J Nutr; 1998 Sep; 80(3):231-4. PubMed ID: 9875062
[TBL] [Abstract][Full Text] [Related]
18. Subacute nicotine co-exposure has no effect on 2,2',3,5',6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat.
Stamou M; Uwimana E; Flannery BM; Kania-Korwel I; Lehmler HJ; Lein PJ
Toxicology; 2015 Dec; 338():59-68. PubMed ID: 26463278
[TBL] [Abstract][Full Text] [Related]
19. AhR and PPARalpha: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11.
Shaban Z; Soliman M; El-Shazly S; El-Bohi K; Abdelazeez A; Kehelo K; Kim HS; Muzandu K; Ishizuka M; Kazusaka A; Fujita S
Xenobiotica; 2005 Jan; 35(1):51-68. PubMed ID: 15788368
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatic cytochrome P450 isozyme composition in the transgenic rat expressing low level human growth hormone.
Takahashi J; Furuhata Y; Ikeda A; Takahashi M; Iwata H; Kazusaka A; Fujita S
Xenobiotica; 1999 Dec; 29(12):1203-12. PubMed ID: 10647907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
